我院2013-2015年麻醉药品应用分析
x

请在关注微信后,向客服人员索取文件

篇名: 我院2013-2015年麻醉药品应用分析
TITLE:
摘要: 目的:评价我院麻醉药品的应用现状及趋势,为麻醉药品的科学管理和合理使用提供参考。方法:对我院2013-2015年麻醉药品的销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)等进行统计、分析。结果:我院麻醉药品销售金额逐年增加,且以注射剂为主。枸橼酸舒芬太尼注射液的销售金额和DDDs在2013-2015年均居首位,盐酸吗啡缓释片和枸椽酸芬太尼注射液的DDDs分列第2、3位。DDC排序列前3位的分别是盐酸羟考酮缓释片(40 mg)、注射用盐酸瑞芬太尼(2 mg)和枸橼酸舒芬太尼注射液。枸橼酸舒芬太尼注射液、盐酸吗啡片和盐酸羟考酮缓释片(10 mg)的B/A值接近1.0,其经济效益和社会效益同步性较好。结论:我院麻醉药品的销售金额逐年增加,麻醉药品的使用和管理基本符合相关标准和治疗规范,但在今后的工作中仍需加强管理。
ABSTRACT: OBJECTIVE: To evaluate the current situation and trend of narcotic drugs used in our hospital, and to provide reference for scientific management and rational use of narcotic drugs. METHODS: The utilization of narcotic drugs in our hospital during 2013-2015 was analyzed statistically in terms of consumption sum, DDDs, DDC and B/A, etc. RESULTS: The consumption sum of narcotic drugs in our hospital increased year by year, mainly injection. Both consumption sum and DDDs of Sufentanil citrate injection took up the first place during 2013-2015, Morphine hydrochloride sustained-release tablets and Fentanyl citrate injection took up 2nd and 3rd place in the list of DDDs.  Top 3 drugs in the list of DDC were Oxycodone hydrochloride prolonged-release tablets (40 mg), Remifentanil hydrochloride for infection (2 mg) and Sufentanil citrate injection. B/A of Sufentanil citrate injection, Morphine hydrochloride tablets and Oxycodone hydrochloride prolonged-release tablets (10 mg) were all close to 1.0, showing good synchronization of economic and social benefits. CONCLUSIONS: The consumption sum of narcotic drugs in our hospital has increased year by year. The utilization and management of narcotic drugs is basically in line with related standard and treatment criteria, but the management of narcotic drugs still need to be strengthened in the future.
期刊: 2017年第28卷第29期
作者: 徐美玲,吴迪,刘颖,刘玲
AUTHORS: XU Meiling,WU Di,LIU Ying,LIU Ling
关键字: 麻醉药品;销售金额;用药频度;日均费用;合理用药
KEYWORDS: Narcotic drugs; Consumption sum; DDDs; DDC; Rational use of drug
阅读数: 179 次
本月下载数: 5 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!